Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) Price & Performance

Ionis Pharmaceuticals Inc. Common StockTrade
ProShares UltraShort Bloomberg Natural Gas ETFTrade

Price performance (Past 24H)

Key statistics

Ionis Pharmaceuticals Inc. Common Stock vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $24.22 (market cap $140.85M). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 50× ProShares UltraShort Bloomberg Natural Gas ETF's market cap, and ProShares UltraShort Bloomberg Natural Gas ETF is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and ProShares UltraShort Bloomberg Natural Gas ETF for 10 Days on average.

IONSKOLD
Market Cap
$7.04B$140.85M
Volume
2,977,4404,297,516
Sector
HealthLeveraged / Inverse
52-Week High
$86.50$49.39
52-Week Low
$42.38$13.58
Typical Hold Time
0 Days10 Days
Enterprise Value
$6.60B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ionis Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

ProShares UltraShort Bloomberg Natural Gas ETF

KOLD is trading at $23.85, down 5.06% over the past 24 hours amid bearish technical signals. The stock shows significant selling pressure with 16 sell signals versus 1 buy signal across technical indicators. Natural gas market fundamentals remain challenging with record-high U.S. production reported by the EIA in July 2026, while geopolitical tensions in the Middle East create volatility in energy markets.

The outlook remains cautious as technical indicators point to continued downward momentum. Investment opportunities exist for contrarian investors given the oversold RSI reading, but risks include persistent natural gas price weakness and high production levels that may pressure energy sector performance in the near term.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IONS
100% Buy0% Sell
Avg holding period · 0 Days
KOLD
90% Buy10% Sell
Avg holding period · 10 Days

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →

About ProShares UltraShort Bloomberg Natural Gas ETF

KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.

Read more on KOLD →